Increase in ubiquity of kidney disorders such as kidney failure or end-stage kidney diseases is driving the global ureteral access sheath market.

The value of the Ureteral Access Sheath market is projected to grow to  USD 1591.2 million  with an estimated CAGR of 4.9% by 2027

Covid-19 Impact & Market Status

A new age for telehealth, medical technology, the Ureteral Access Sheath, and remote monitoring was inaugurated with COVID-19. The largest influence has been on medical devices and ureteral access sheaths, despite the fact that COVID-19's widespread consequences have given rise to a "new normal" for the globe. The growth of the market has been negatively impacted by the closure of numerous production facilities in North America, Europe, and Asia Pacific. The closing of several facilities and factories has had a detrimental influence on the production, timely delivery, and sales of goods on the international market. After 2021, however, it is anticipated that the global Ureteral Access Sheath market would stabilize.

Inner Diameter Fr Below 10 to Emerge as the Most Lucrative Segment

The global ureteral access sheath market is divided into Inner Diameter Fr below 10, Inner Diameter Fr 10–12, and Inner Diameter Fr 13–15 based on kind. Due to its low price and simplicity of use, the inner diameter fr below 10 segment accounted for a major share and is anticipated to maintain its dominance during the projection period. This section is expected to be the most profitable over the anticipated time because to the substantial usage of this in the medical business and its inexpensive cost, which benefits the most number of people.

Clinic Segment to Remain Atop

Due to its high usage rate among doctors who like it over other sectors due to their simple handling, inexpensive, and availability in various sizes, the clinic market dominated for the biggest share and is projected to maintain its dominance during the projection period. The main aspects to watch over the forecasting period are the rising prevalence of chronic kidney disease and other urological disorders, as well as the rising number of urological disease procedures.

The North America Offers Lucrative Investment Opportunities

Due to the abundance of manufacturers, technical improvements brought on by an ageing population and increased brand awareness of new products and technologies, the North American area has a sizable market. Regional medical device businesses in North America are beginning to form alliances, which is increasing the workforce in other industries as well as the effectiveness of the healthcare delivery system. The North American regions, which presently have the largest market share, are anticipated to develop rapidly and maintain their dominance in the global ureteral access sheath market over the projection period.

The increasing necessity of improving existing patient outcomes and invent technologically advanced product to restrain long-term prices required for treating kidney related disorders is improving the reliance on ureteral access sheath furthering the development of global ureteral access sheath market.

The global ureteral access sheath market is estimated to be worth USD 627.4 million by 2029 and grow at an annualized growth rate of 5.5% through the projected period 2022-2029. This global ureteral access sheath market is expanding as a result of factors such the increased frequency of urinary tract infections and the prevalence of chronic kidney disease, both of which are increasing the number of patients who need ureteral access sheaths for long-term care.

A ureteral access sheath is essentially a way to repeatedly ascend and descend the ureter without having to reintroduce guidewires. The outer diameter of sheaths ranges from 10F to 16F. The ureteral access sheath or device (UAS) promotes the use of flexible ureteroscopy, enabling more minimally intrusive management of difficult upper urinary tract infections or disorders. The retrograde passage of the UAS, which is available in a range of widths and lengths, is assisted by a hydrophilic coating and other components designed to provide a smooth entry into the ureter with sufficient resistance to crimping and clasping.

Ureteral access sheaths (UASs) make it easier to enter the collecting system repeatedly, which may have a number of advantages, such as increased operative visibility, the possibility of obtaining stone fragments, a lower risk of infection due to lower intra-renal pressures, and possibly longer reusable life. Additionally, is used to make flexible ureteroscopy easier for treating urolithiasis.

Utilizing a ureteral access sheath has the advantage of enabling the use of the ureteroscope while minimizing damage to the ureter, improving fluid flow and vision within the urethra increasing both the effectiveness of the process and lowering the cost.

Companies are releasing cutting-edge medical equipment that will enhance patient outcomes and reduce hospital stays. However, during the projection period, there is some concerns about regulatory uncertainty, limited physician advice in choosing the best medical device, reimbursement coverage and accuracy, or the early stages of technology. These forces are likely to hamper the global ureteral access sheath market. Furthermore, increasing prevalence of kidney disorders, technological intervention leading to development of advanced and efficient products, rising research and development activities are some key factors anticipated to provide lucrative growth opportunity for the global ureteral access sheath market.

The key players in this global ureteral access sheath market are Applied Medical, Coloplast, Boston Scientific, Rocamed, BD, Amecath, Olympus, Cook Medical, and Envaste among others.

Latest Innovations in the Global Ureteral Access Sheath Market: A Snapshot

• During endoscopic urological operations, the MEDpro Ureteral Access Sheath is used to create a conduit, allowing the entry of endoscopes and other equipment into the urinary system. The sheath is blue, while the Dilator is white. Both come in sterile peel-open packages and are only meant to be used once.
• The new GLIDEWAYTM Ureteral Access Sheath was introduced in the United States today by TERUMO, a well-known international manufacturer of medical devices. Current urologic interventions using conventional access sheaths have been linked to complications and injuries such perforation and severe bleeding. 1,2 The brand-new line of GLIDEWAYTM Access Sheaths is equipped with cutting-edge and honed features that are intended to reduce trauma while ensuring maximal and effective access.

Ureteral Access Sheath Market Scope

Key Segments of the Global Ureteral Access Sheath Market

Type Overview, 2022-2029 (USD Million)

• Inner Diameter Fr below 10
• Inner Diameter Fr 10-12
• Inner Diameter Fr 13-15

Application Overview, 2022-2029 (USD Million)

• Hospital
• Clinic

Regional Overview, 2019-2029 (USD Million)

North America

• U.S
• Canada

Europe

• Germany
• France
• UK
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• Rest of Asia Pacific

South America

• Mexico
• Brazil
• Rest of South America

Middle East and South Africa